According to CMS’s recent release of the 2020 star quality ratings, an overwhelming percentage of Medicare Advantage beneficiaries continue to enroll in plans with 4 or more stars. There was also a notable shift of membership into highly rated Prescription Drug Plans, some of which made meaningful improvements on an individual basis even though PDP performance on average was stagnant.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.